You are here

Research

Oral antiviral simnotrelvir shows promise for treating mild COVID-19 --study

 

..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Long Covid: Change in a handful of blood proteins may pave way to tests and treatment --study

https://www.nbcnews.com/health/health-news/long-covid-cause-study-immune-system-complement-response-rcna134530

Scientists have identified a persistent change in a handful of blood proteins in people with long Covid that indicates that an important part of their immune system remains on high alert for months after an acute infection.

The findings, published Thursday in the journal Science, could help explain what causes the persistent fatigue, brain fog and other debilitating symptoms of long Covid, as well as pave the way for diagnostic tests and potentially, a long-awaited treatment, experts say. 

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

US and UK announce biosecurity alliance to counter pandemics and bioterrorism

 

The UK and US have agreed to work together to counter growing biological threats such as pandemics, antimicrobial resistance and bioterrorism.

The two nations announced a new strategic dialogue on biosecurity on Tuesday.

...

Problem, Solution, SitRep, or ?: 

New British study on How Long Does It Take to Get COVID-19

The length of time you spend around a person with COVID-19 seems to heavily influence your likelihood of getting sick, according to a recent Nature study that has been peer-reviewed but not fully edited. Most exposures that result in transmission last at least an hour, if not much longer, the researchers say.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks